Reed Thomas D. 4
4 · INTREXON CORP · Filed Jan 7, 2020
Insider Transaction Report
Form 4
Reed Thomas D.
DirectorChief Science Officer
Transactions
- Exercise/Conversion
Common Stock
2020-01-04+18,940→ 154,304 total - Sale
Common Stock
2020-01-06$5.83/sh−5,416$31,571→ 148,888 total - Exercise/Conversion
Restricted Stock Units
2020-01-04−18,940→ 56,818 total→ Common Stock (18,940 underlying)
Holdings
- 62,840(indirect: By Trust)
Common Stock
- 41,705(indirect: By Trust)
Common Stock
- 2,440(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- [F2]This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
- [F3]Held by the Thomas David Reed Living Trust dated February 4, 2011.
- [F4]Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011.
- [F5]The restricted stock units were granted on January 4, 2019, and the remaining restricted stock units vest in three equal annual installments on each of January 4, 2021, 2022 and 2023.